09/15/21 7:00 AMNasdaq : INDPIndaptus Therapeutics Receives Notice of Allowance for Strategic PatentIndaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the United States Patent and Trademark Office has issued a notice of allowanceRHEA-AIneutral
